|
|
|
|
Document Preview Asset Purchase Agreement |
||||
|
|
||||
|
Click "Add to Cart" button to purchase document. |
||||
|
|
||||
|
Title: |
Asset Purchase Agreement |
|||
|
Entities: |
Pioneer Hi Bred International Inc.; Tapestry Pharmaceuticals, Inc.; Venture Law Group |
|||
|
Date: |
2003 |
|||
|
Size: |
Preview shows 51KB of 144KB total |
|||
|
Price: |
$62 |
|||
|
ID: |
#328371 |
|||
|
|
||||
|
||||
|
|
||||
|
Start of Preview |
||||
ASSET PURCHASE AGREEMENT
BETWEEN
NAPRO BIOTHERAPEUTICS, INC.
AND
PANGENE CORPORATION
DECEMBER 31, 2002
TABLE OF CONTENTS
|
Page | ||||
|
1. Definitions |
1 | |||
|
2. Basic Transaction |
8 | |||
|
(a) Purchase and Sale of Assets |
8 | |||
|
(b) Assumption of Liabilities |
8 | |||
|
(c) Purchase Price |
8 | |||
|
(d) First Closing |
8 | |||
|
(e) Deliveries at First Closing |
9 | |||
|
(f) Second Closing |
9 | |||
|
(g) Prorations |
9 | |||
|
(h) Procedures for Assets Not Transferred |
9 | |||
|
(i) Procedures for Invalid Partial Assignments |
10 | |||
|
(j) Sales and Transfer Taxes |
10 | |||
|
(k) Allocation |
10 | |||
|
(l) Risk of Loss |
10 | |||
|
3. Sellers Representations and Warranties |
10 | |||
|
(a) Organization of Seller |
11 | |||
|
(b) Authorization of Transaction |
11 | |||
|
(c) Noncontravention |
11 | |||
|
(d) Brokers Fees |
11 | |||
|
(e) Title to Assets; Sufficiency of Assets |
11 | |||
|
(f) Financial Statements |
12 | |||
|
(g) Events Subsequent to July 31, 2002 |
13 | |||
|
(h) Undisclosed Liabilities |
15 | |||
|
(i) Legal Compliance |
15 | |||
|
(j) Tax Matters |
15 | |||
|
(k) Intellectual Property |
16 | |||
|
(l) Inventory |
18 | |||
|
(m) Contracts |
18 | |||
|
(n) Notes and Accounts Receivable |
18 | |||
|
(o) Powers of Attorney |
19 | |||
|
(p) Insurance |
19 | |||
|
(q) Litigation |
19 | |||
|
(r) Product Warranty |
19 | |||
|
(s) Product Liability |
19 | |||
|
(t) Employees |
19 | |||
|
(u) Employee Benefits |
20 | |||
|
(v) Certain Business Relationships With Seller |
20 | |||
|
(w) Customers and Suppliers |
20 | |||
|
(x) Regulatory Matters |
21 | |||
|
(y) Solvency |
22 | |||
|
(z) Disclosure |
22 | |||
|
4. Buyers Representations and Warranties |
22 | |||
|
(a) Organization of Buyer |
22 | |||
|
(b) Authorization of Transaction |
22 | |||
|
(c) Noncontravention |
23 | |||
|
(d) Brokers Fees |
23 | |||
ii
|
Page | ||||
|
(e) Financing |
23 | |||
|
5. Conditions to Obligation to Close at First Closing |
23 | |||
|
(a) Conditions to Buyers Obligation |
23 | |||
|
(b) Conditions to Sellers Obligation |
25 | |||
|
6. Conditions to Obligation to Close at Second Closing |
25 | |||
|
(a) Conditions to Buyers Obligation |
25 | |||
|
7. Remedies for Breaches of This Agreement |
26 | |||
|
(a) Survival of Representations and Warranties |
26 | |||
|
(b) Indemnification Provisions for Benefit of Buyer |
26 | |||
|
(c) Indemnification Provisions for Benefit of Seller |
27 | |||
|
(d) Indemnification Claims |
28 | |||
|
(e) Limitation on Remedies |
30 | |||
|
(f) Losses Threshold |
30 | |||
|
(g) Maximum Indemnification Amount |
30 | |||
|
(h) Bulk Sales Compliance |
30 | |||
|
8. Termination |
31 | |||
|
(a) Termination of Agreement |
31 | |||
|
(b) Effect of Termination |
31 | |||
|
9. Post-Closing Covenants |
31 | |||
|
(a) Daikin Patents |
31 | |||
|
(b) Technology Transfer Services |
31 | |||
|
(c) Employees and Employee Benefits |
32 | |||
|
(d) Confidentiality |
33 | |||
|
(e) Non-Competition |
33 | |||
|
(f) Amendment of Invitrogen and Pioneer Licenses |
34 | |||
|
(g) Further Assurances |
34 | |||
|
10. Miscellaneous |
34 | |||
|
(a) Press Releases and Public Announcements |
35 | |||
|
(b) No Third-Party Beneficiaries |
35 | |||
|
(c) Entire Agreement |
35 | |||
|
(d) Succession and Assignment |
35 | |||
|
(e) Counterparts |
35 | |||
|
(f) Headings |
35 | |||
|
(g) Notices |
35 | |||
|
(h) Governing Law |
36 | |||
|
(i) Amendments and Waivers |
36 | |||
|
(j) Severability |
36 | |||
|
(k) Expenses |
36 | |||
|
(l) Construction |
37 | |||
|
(m) Incorporation of Annexes, Exhibits and the Disclosure Schedules |
37 | |||
|
(n) Specific Performance |
37 | |||
|
(o) Submission to Jurisdiction |
37 | |||
|
(p) Governing Language |
38 | |||
iii
Annex ADaikin Patents
Annex BClaims
Annex CContracts
Annex DGenomics Business Intellectual Property
Annex EPersons to Whom Knowledge is Attributable
Annex FRecords
Annex GTangible Personal Property
Annex HContracts, Property and Rights Which May Not Be Assigned
Exhibit AEscrow Agreement
Exhibit BAssignment and Assumption Agreement
Exhibit CBill of Sale
Exhibit DSeller Consolidated Financial Statements
Exhibit EEstimated Genomics Business Financials
Exhibit FCross-License Agreement
Seller Disclosure ScheduleExceptions to Representations and Warranties
|
End of Preview |
Home Intelligence Services Subscriptions News About Us